ZOLL Respicardia, Inc.
$718.3K 1,630 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Carl Zeiss Meditec USA, Inc.
Carl Zeiss Meditec USA, Inc. reported $719,283.57 across General Payments, Research, and Ownership to 2,435 physicians and teaching hospitals across 2,435 transactions.
- $719.3K Above-median payer
- All-tracks total
- 2,435 Top quartile volume
- Transactions
- 2,435 Top quartile reach
- Recipients
- −$39.4K
- General Payments vs PY2023
Carl Zeiss Meditec USA, Inc. reported $719,283.57 across all CMS Open Payments tracks (General + Research + Ownership) to 2,435 physicians and teaching hospitals in Program Year 2024 - ranking #687 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $719,283.57, averaging $295.39 per recipient.
How Carl Zeiss Meditec USA, Inc.'s $719.3K all-tracks total breaks down
Carl Zeiss Meditec USA, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
41/100
Total payments
F
17/100
Transaction volume
F
28/100
Physician reach
F
28/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer carl-zeiss-meditec-usa-inc Carl Zeiss Meditec USA, Inc.
$719.3K · #687/1,925 · 0.0% industry · PY2024
- TOT $719.3K
- RANK #687
- SHARE 0.0%
- TXN 2,435
- RCP 2,435
- CAT 7
- GEN $719.3K
- ΔGEN −$39.4K
- TOP1 16.7%
- PY 2024
Volume peers
Nearest volume peer: ZOLL Respicardia, Inc. ($718.3K)
Carl Zeiss Meditec USA, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Carl Zeiss Meditec USA, Inc.'s CMS-reported General Payments decreased by $39.4K (−5.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CARL ZEISS MEDITEC USA, INC.PY2023: CARL ZEISS MEDITEC USA, INC.PY2024: Carl Zeiss Meditec USA, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $758,639.71
- PY2024
- $719,283.57
What the Data Shows for Carl Zeiss Meditec USA, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Carl Zeiss Meditec USA, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $297.9K, accounting for 41.4% of this company's General Payments and 102 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Carl Zeiss Meditec USA, Inc.'s 7-category general-payment breakdown at $297.9K, 41.4% of the reported total.
Carl Zeiss Meditec USA, Inc. reports 7 general-payment categories - the top three are Consulting Fee (41.4%), Food and Beverage (18.7%), and Travel and Lodging (13.5%). The remaining 4 categories make up 26.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Carl Zeiss Meditec USA, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $297.9K | 102 | 41.4% |
| Food and Beverage | $134.4K | 1,909 | 18.7% |
| Travel and Lodging | $97.2K | 315 | 13.5% |
| Compensation for Services Other Than Consulting | $83.7K | 46 | 11.6% |
| Long-Term Medical Supply or Device Loan | $74.7K | 30 | 10.4% |
| Debt Forgiveness | $23.4K | 23 | 3.3% |
| Education | $8.0K | 10 | 1.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $193,623.05 (26.9%) of $719,283.57 in this company's General Payments records across 1,494 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Carl Zeiss Meditec USA, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Jon Gordon Dishler
$120,000.00 across 2 reported transactions
- 2
Adventhealth Orlando
$21,985.41 across 1 reported transactions
- 3
Largo Medical Center
$21,648.49 across 2 reported transactions
- 4
Omar Razzaque Shakir
$17,223.03 across 18 reported transactions
- 5
Jorge a Fortun
$12,766.12 across 8 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Carl Zeiss Meditec USA, Inc. ranks #687 of 1,925 by total payments (top 36% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,422 of 1,838 by HHI (bottom 23% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Moximed, Inc : $1.8K total payments, HHI 353
- Edwards Lifesciences Corporation : $27.8M total payments, HHI 353
- Endo USA, Inc. : $1.5M total payments, HHI 351
- Thommen Medical USA, LLC : $89.6K total payments, HHI 351
- OPKO Pharmaceuticals, LLC : $235.7K total payments, HHI 350
- Teleflex LLC : $5.6M total payments, HHI 349
- Carl Zeiss Meditec USA, Inc. (this company) : $719.3K total payments, HHI 348
- Checkpoint Surgical, Inc : $293.7K total payments, HHI 348
- Medline Industries LP : $1.9M total payments, HHI 347
- Olympus Corporation : $904.0K total payments, HHI 343
- Coherus Biosciences Inc. : $361.8K total payments, HHI 343
- Orphalan Inc : $61.9K total payments, HHI 342
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Carl Zeiss Meditec USA, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Carl Zeiss Meditec USA, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Carl Zeiss Meditec USA, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Scilex Pharmaceuticals Inc.
$715.7K 19,348 recipients
Compare payment profiles
Kuros Biosciences USA, Inc
$711.3K 1,447 recipients
Compare payment profiles
Napo Pharmaceuticals Inc
$704.8K 1,430 recipients
Compare payment profiles
SurGenTec
$704.8K 249 recipients
Compare payment profiles
Calvary Spine, LLC
$703.2K 0 recipients
Compare payment profiles
Put this to use
Carl Zeiss Meditec USA, Inc. ranks #687 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Carl Zeiss Meditec USA, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.